BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38479481)

  • 1. Comparative histologic features among liver biopsies with biliary-pattern injury and confirmed clinical diagnoses.
    Yu S; Vidal B; Peric M; Rosenbaum MW; Cates JMM; Gonzalez RS
    Hum Pathol; 2024 Apr; 146():8-14. PubMed ID: 38479481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis.
    Yang J; Yu YL; Jin Y; Zhang Y; Zheng CQ
    World J Gastroenterol; 2016 Sep; 22(33):7579-86. PubMed ID: 27672278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile ductal injury and ductular reaction are frequent phenomena with different significance in autoimmune hepatitis.
    Verdonk RC; Lozano MF; van den Berg AP; Gouw AS
    Liver Int; 2016 Sep; 36(9):1362-9. PubMed ID: 26849025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratin 7 expression in hepatic cholestatic diseases.
    Sakellariou S; Michaelides C; Voulgaris T; Vlachogiannakos J; Manesis E; Tiniakos DG; Delladetsima I
    Virchows Arch; 2021 Oct; 479(4):815-824. PubMed ID: 34312700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
    Kleiner DE; Chalasani NP; Lee WM; Fontana RJ; Bonkovsky HL; Watkins PB; Hayashi PH; Davern TJ; Navarro V; Reddy R; Talwalkar JA; Stolz A; Gu J; Barnhart H; Hoofnagle JH;
    Hepatology; 2014 Feb; 59(2):661-70. PubMed ID: 24037963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cholestatic liver diseases].
    Grimm D; Thimme R
    Ther Umsch; 2011 Apr; 68(4):195-9. PubMed ID: 21452140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
    Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
    Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholangitis: a histologic classification based on patterns of injury in liver biopsies.
    Li Y; Ayata G; Baker SP; Banner BF
    Pathol Res Pract; 2005; 201(8-9):565-72. PubMed ID: 16259109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of biliary fibrosis.
    Pinzani M; Luong TV
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1279-1283. PubMed ID: 28754450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting.
    Bosch DE; Zen Y; Boukhar SA; Liu Y; Cheng L; Yeh MM
    Virchows Arch; 2021 Dec; 479(6):1131-1143. PubMed ID: 34414507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of langerhans cell infiltrate by CD1a immunostain in liver biopsy for the diagnosis of primary biliary cirrhosis.
    Graham RP; Smyrk TC; Zhang L
    Am J Surg Pathol; 2012 May; 36(5):732-6. PubMed ID: 22498823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peribiliary vascular plexus in primary sclerosing cholangitis and primary biliary cirrhosis.
    Washington K; Clavien PA; Killenberg P
    Hum Pathol; 1997 Jul; 28(7):791-5. PubMed ID: 9224746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary Cholangitis.
    Carpino G; Cardinale V; Folseraas T; Overi D; Floreani A; Franchitto A; Onori P; Cazzagon N; Berloco PB; Karlsen TH; Alvaro D; Gaudio E
    Am J Pathol; 2018 Mar; 188(3):627-639. PubMed ID: 29248458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune overlapping syndromes.
    Poupon R
    Clin Liver Dis; 2003 Nov; 7(4):865-78. PubMed ID: 14594134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis.
    Dienes HP; Lohse AW; Gerken G; Schirmacher P; Gallati H; Löhr HF; Meyer zum Büschenfelde KH
    Virchows Arch; 1997 Aug; 431(2):119-24. PubMed ID: 9293893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology of cholestasis.
    Desmet VJ
    Verh Dtsch Ges Pathol; 1995; 79():233-40. PubMed ID: 8600686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].
    Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D
    Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmune liver diseases].
    Fischer HP; Goltz D
    Pathologe; 2020 Sep; 41(5):444-456. PubMed ID: 32749523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease.
    Palmer M; Regev A; Lindor K; Avigan MI; Dimick-Santos L; Treem W; Marcinak JF; Lewis JH; Anania FA; Seekins D; Shneider BL; Chalasani N
    Aliment Pharmacol Ther; 2020 Jan; 51(1):90-109. PubMed ID: 31762074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.